These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37982142)

  • 41. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
    Maccioni RB; Otth C; Concha II; Muñoz JP
    Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of TRPA1 channel activity by Cdk5 in sensory neurons.
    Sulak MA; Ghosh M; Sinharoy P; Andrei SR; Damron DS
    Channels (Austin); 2018 Jan; 12(1):65-75. PubMed ID: 29308980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons.
    Kesavapany S; Amin N; Zheng YL; Nijhara R; Jaffe H; Sihag R; Gutkind JS; Takahashi S; Kulkarni A; Grant P; Pant HC
    J Neurosci; 2004 May; 24(18):4421-31. PubMed ID: 15128856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
    Asada A; Saito T; Hisanaga S
    J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5).
    Calderón-Rivera A; Sandoval A; González-Ramírez R; González-Billault C; Felix R
    PLoS One; 2015; 10(3):e0119134. PubMed ID: 25760945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1.
    Pareek TK; Keller J; Kesavapany S; Agarwal N; Kuner R; Pant HC; Iadarola MJ; Brady RO; Kulkarni AB
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):660-5. PubMed ID: 17194758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
    Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
    J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
    Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y
    J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Cdk5/p35 kinases modulate leptin-induced STAT3 signaling.
    He Y; Kastin AJ; Hsuchou H; Pan W
    J Mol Neurosci; 2009 Sep; 39(1-2):49-58. PubMed ID: 19156541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
    Lee JH; Kim KT
    J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral and orofacial pain sensation is unaffected by the loss of p39.
    Prochazkova M; Hall B; Hu M; Okine T; Reukauf J; Binukumar BK; Amin ND; Roque E; Pant HC; Kulkarni A
    Mol Pain; 2017; 13():1744806917737205. PubMed ID: 28969475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
    Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
    J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclin I and p35 determine the subcellular distribution of Cdk5.
    Hagmann H; Taniguchi Y; Pippin JW; Kauerz HM; Benzing T; Shankland SJ; Brinkkoetter PT
    Am J Physiol Cell Physiol; 2015 Feb; 308(4):C339-47. PubMed ID: 25500740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CDK5 contributes to neuronal apoptosis via promoting MEF2D phosphorylation in rat model of intracerebral hemorrhage.
    Ke K; Shen J; Song Y; Cao M; Lu H; Liu C; Shen J; Li A; Huang J; Ni H; Chen X; Liu Y
    J Mol Neurosci; 2015 May; 56(1):48-59. PubMed ID: 25417143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte.
    He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y
    Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3.
    Li BS; Zhang L; Takahashi S; Ma W; Jaffe H; Kulkarni AB; Pant HC
    EMBO J; 2002 Feb; 21(3):324-33. PubMed ID: 11823425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.
    Nikolic M; Chou MM; Lu W; Mayer BJ; Tsai LH
    Nature; 1998 Sep; 395(6698):194-8. PubMed ID: 9744280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphorylation of drebrin by cyclin-dependent kinase 5 and its role in neuronal migration.
    Tanabe K; Yamazaki H; Inaguma Y; Asada A; Kimura T; Takahashi J; Taoka M; Ohshima T; Furuichi T; Isobe T; Nagata K; Shirao T; Hisanaga S
    PLoS One; 2014; 9(3):e92291. PubMed ID: 24637538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis.
    Pareek TK; Lam E; Zheng X; Askew D; Kulkarni AB; Chance MR; Huang AY; Cooke KR; Letterio JJ
    J Exp Med; 2010 Oct; 207(11):2507-19. PubMed ID: 20937706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.